Join Us in Advancing Cancer Research from Home.
Funded in part by the National Cancer Institute.
If you are scheduled to start radiation treatment in the abdominal or pelvic area to fight cancer, join RADIANT and contribute to advancing cancer research from home.
Radiation therapy plays an important role in the fight against cancer. Yet, despite its excellent safety profile, about 10% of patients will experience an adverse reaction to the therapy and some patients may not benefit from the therapy at all. The researchers behind the RADIANT study are developing a blood test to help doctors predict a patient’s response to radiation treatment. LEARN MORE
Around the country, people recently diagnosed with cancer and about to undergo radiation treatment in the abdominal or pelvic area are joining RADIANT to help advance cancer research from home.
This project has been funded in whole or in part with Federal funds from the National Cancer Institute, National Institutes of Health, Department of Health and Human Services, under Contract No. HHSB261201600051C